Contributing Data

Populating the WWARN database with timely data depends entirely on groups like yours contributing their data. The more representative the data are, geographically, temporally and demographically, the more useful they will be for accurately defining drug resistance and for facilitating optimal use of antimalarial drugs. For example, there are very limited data published on antimalarial drug concentrations in infants. By pooling data from all studies conducted in young children, some of which would have included a number of infants, we expect to be able to determine whether these levels differ between infants and young children.

Given the importance of this ambitious initiative, a number of strategies are being developed to make it easier for groups like yours to share comparable data, including:

• Providing tools for collecction and organization of antimalarial resistance data (e.g. Case Record Forms, Sample size calculation, Database templates)
• Recommended Practice Guidelines for Sample Collection, storage, transport, extraction and assay, data analysis and reporting.
• Potentially providing certain key reference materials.

Contact Us if you may have relevant data on antimalarial resistance (clinical, molecular or in vitro) and / or pharmacokinetics to contribute to the WWARN database.